Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer

por Okugawa, Y, Miki, C, Toiyama, Y, Yasuda, H, Yokoe, T, Saigusa, S, Hiro, J, Tanaka, K, Inoue, Y, Kusunoki, M
Publicado 2010

Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract

por Wu, C-F, Ng, K-F, Chen, C-S, Chang, P-L, Chuang, C-K, Weng, W-H, Liao, S-K, Pang, S-T
Publicado 2010

A multi-analyte serum test for the detection of non-small cell lung cancer

por Farlow, E C, Vercillo, M S, Coon, J S, Basu, S, Kim, A W, Faber, L P, Warren, W H, Bonomi, P, Liptay, M J, Borgia, J A
Publicado 2010

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

por Gómez-Benito, M, Conchillo, A, García, M A, Vázquez, I, Maicas, M, Vicente, C, Cristobal, I, Marcotegui, N, García-Ortí, L, Bandrés, E, Calasanz, M J, Alonso, M M, Odero, M D
Publicado 2010

Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways

por Sitaram, R T, Degerman, S, Ljungberg, B, Andersson, E, Oji, Y, Sugiyama, H, Roos, G, Li, A
Publicado 2010

Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells

por Almstrup, K, Nielsen, J E, Mlynarska, O, Jansen, M T, Jørgensen, A, Skakkebæk, N E, Rajpert-De Meyts, E
Publicado 2010

(1)H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice

por Hekmatyar, S K, Wilson, M, Jerome, N, Salek, R M, Griffin, J L, Peet, A, Kauppinen, R A
Publicado 2010

Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development

por Kesselring, R, Thiel, A, Pries, R, Trenkle, T, Wollenberg, B
Publicado 2010

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

por Zhang, J, Yang, Y, Yang, T, Liu, Y, Li, A, Fu, S, Wu, M, Pan, Z, Zhou, W
Publicado 2010

Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells

por Mern, D S, Hasskarl, J, Burwinkel, B
Publicado 2010

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado 2010

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

por Koukourakis, M I, Giatromanolaki, A, Sivridis, E, Pitiakoudis, M, Gatter, K C, Harris, A L
Publicado 2010

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

por Abajo, A, Rodriguez, J, Bitarte, N, Zarate, R, Boni, V, Ponz, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J
Publicado 2010

Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation

por Ash, S, Stein, J, Askenasy, N, Yaniv, I
Publicado 2010

Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase

por Devy, J, Duca, L, Cantarelli, B, Joseph-Pietras, D, Scandolera, A, Rusciani, A, Parent, L, Thevenard, J, Pasco, S Brassart, Tarpin, M, Martiny, L, Debelle, L
Publicado 2010

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

por Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F
Publicado 2010

Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor

por Michael, M, Vlahovic, G, Khamly, K, Pierce, K J, Guo, F, Olszanski, A J
Publicado 2010

Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma

por Kasparian, N A, McLoone, J K, Meiser, B, Butow, P N, Simpson, J M, Mann, G J
Publicado 2010

Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy

por Hong, A M, Dobbins, T A, Lee, C S, Jones, D, Harnett, G B, Armstrong, B K, Clark, J R, Milross, C G, Kim, J, O'Brien, C J, Rose, B R
Publicado 2010

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

por Al-Batran, S-E, Güntner, M, Pauligk, C, Scholz, M, Chen, R, Beiss, B, Stopatschinskaja, S, Lerbs, W, Harbeck, N, Jäger, E
Publicado 2010